Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $215.68 | 13 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Lilly USA, LLC | $65.37 | 4 | $0 (2023) |
| GlaxoSmithKline, LLC. | $45.98 | 3 | $0 (2023) |
| Organon LLC | $28.92 | 2 | $0 (2022) |
| Gilead Sciences, Inc. | $24.29 | 1 | $0 (2021) |
| Exact Sciences Corporation | $21.68 | 1 | $0 (2024) |
| Biohaven Pharmaceuticals, Inc. | $17.55 | 1 | $0 (2021) |
| Merck Sharp & Dohme Corporation | $11.89 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $21.68 | 1 | Exact Sciences Corporation ($21.68) |
| 2023 | $30.91 | 2 | GlaxoSmithKline, LLC. ($18.18) |
| 2022 | $12.54 | 1 | Organon LLC ($12.54) |
| 2021 | $122.75 | 7 | Lilly USA, LLC ($52.64) |
| 2020 | $27.80 | 2 | GlaxoSmithKline, LLC. ($27.80) |
All Payment Transactions
13 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/31/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $21.68 | General |
| Category: Oncology | ||||||
| 09/01/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), SHINGRIX, AREXVY | Food and Beverage | In-kind items and services | $18.18 | General |
| Category: RESPIRATORY | ||||||
| 07/13/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $12.73 | General |
| Category: Diabetes | ||||||
| 04/21/2022 | Organon LLC | NEXPLANON (Drug) | Food and Beverage | In-kind items and services | $12.54 | General |
| Category: ETONOGESTREL | ||||||
| 11/10/2021 | Gilead Sciences, Inc. | Epclusa (Drug) | Food and Beverage | In-kind items and services | $24.29 | General |
| Category: HCV | ||||||
| 11/04/2021 | Organon LLC | NEXPLANON (Drug) | Food and Beverage | In-kind items and services | $16.38 | General |
| Category: CONTRACEPTIVES | ||||||
| 08/25/2021 | Lilly USA, LLC | EMGALITY (Drug) | Food and Beverage | In-kind items and services | $11.54 | General |
| Category: Neuroscience | ||||||
| 07/20/2021 | Biohaven Pharmaceuticals, Inc. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $17.55 | General |
| Category: PRIMARY CARE | ||||||
| 04/19/2021 | Merck Sharp & Dohme Corporation | NEXPLANON (Drug) | Food and Beverage | In-kind items and services | $11.89 | General |
| Category: WOMENS HEALTH | ||||||
| 02/25/2021 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $18.83 | General |
| Category: Diabetes | ||||||
| 01/29/2021 | Lilly USA, LLC | TRULICITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $22.27 | General |
| Category: Diabetes | ||||||
| 11/13/2020 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $12.50 | General |
| Category: RESPIRATORY | ||||||
| 06/25/2020 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.30 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 794 | 1,730 | $213,885 | $62,527 |
| 2022 | 11 | 256 | 402 | $64,619 | $21,087 |
| 2021 | 2 | 26 | 26 | $46,238 | $2,855 |
All Medicare Procedures & Services
30 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 135 | 332 | $88,246 | $27,827 | 31.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 78 | 144 | $25,482 | $8,190 | 32.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 46 | 46 | $12,834 | $5,624 | 43.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 86 | 86 | $22,790 | $4,756 | 20.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 27 | 35 | $12,495 | $4,641 | 37.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 29 | 29 | $11,890 | $2,903 | 24.4% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 14 | 14 | $5,880 | $2,195 | 37.3% |
| G0179 | Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 2023 | 21 | 53 | $5,512 | $1,571 | 28.5% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 76 | 131 | $8,122 | $1,238 | 15.2% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 20 | 26 | $3,536 | $1,019 | 28.8% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2023 | 18 | 19 | $2,375 | $657.78 | 27.7% |
| J1040 | Injection, methylprednisolone acetate, 80 mg | Office | 2023 | 60 | 75 | $1,425 | $611.23 | 42.9% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 44 | 57 | $447.00 | $414.96 | 92.8% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 30 | 41 | $1,066 | $390.32 | 36.6% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2023 | 15 | 21 | $630.00 | $340.62 | 54.1% |
| 81003 | Automated urinalysis test | Office | 2023 | 33 | 46 | $1,380 | $99.31 | 7.2% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 62 | 575 | $9,775 | $50.14 | 0.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 49 | 82 | $21,812 | $7,595 | 34.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 31 | 31 | $8,649 | $3,776 | 43.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 31 | 31 | $12,710 | $3,631 | 28.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 30 | 41 | $7,192 | $2,453 | 34.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 30 | 30 | $7,950 | $2,156 | 27.1% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 11 | 14 | $1,238 | $594.93 | 48.1% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2022 | 11 | 12 | $1,500 | $494.28 | 33.0% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 18 | 22 | $1,364 | $215.95 | 15.8% |
About Dr. Lindsey French-Hoffman, DO
Dr. Lindsey French-Hoffman, DO is a Family Medicine healthcare provider based in Kingston, Oklahoma. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/10/2019. The National Provider Identifier (NPI) number assigned to this provider is 1083266084.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Lindsey French-Hoffman, DO has received a total of $215.68 in payments from pharmaceutical and medical device companies, with $21.68 received in 2024. These payments were reported across 13 transactions from 7 companies. The most common payment nature is "Food and Beverage" ($215.68).
As a Medicare-enrolled provider, French-Hoffman has provided services to 1,076 Medicare beneficiaries, totaling 2,158 services with total Medicare billing of $86,469. Data is available for 3 years (2021–2023), covering 30 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Kingston, OK
- Active Since 07/10/2019
- Last Updated 01/21/2026
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1083266084
Products in Payments
- TRELEGY ELLIPTA (Drug) $45.98
- NEXPLANON (Drug) $40.81
- Epclusa (Drug) $24.29
- TRULICITY (Drug) $22.27
- Cologuard Collection Kit (Device) $21.68
- JARDIANCE (Drug) $18.83
- NURTEC ODT (Drug) $17.55
- MOUNJARO (Drug) $12.73
- EMGALITY (Drug) $11.54
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Kingston
Dr. Bhavana Vora, M.d, M.D
Family Medicine — Payments: $26,080
Dr. Anthony Giardina, Do, DO
Family Medicine — Payments: $18,643
Dr. Elizabeth Costley, Do, DO
Family Medicine — Payments: $14,780
Dr. Ira Vohra, M.d, M.D
Family Medicine — Payments: $9,915
Francesca Hilmi, Do, DO
Family Medicine — Payments: $8,986
Louise Breakstone, M.d, M.D
Family Medicine — Payments: $7,830